Clinical Topics & News

Interview with Mary Alissa Willis, MD, on MS and Mental Health


 

2. Minden SL, Schiffer RB. Affective disorders in multiple sclerosis. Review and recommendations for clinical research. Arch Neurol . 1990;47(1):98-104.

3. Marrie RA, Walld R, Bolton JM, et al; CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease. Estimating annual prevalence of depression and anxiety disorder in multiple sclerosis using administrative data. BMC Res Notes . 2017;10(1):619.

4. Passamonti L. Cerasa A, Liguori M, et al. Neurobiological mechanisms underlying emotional processing in relapsing-remitting multiple sclerosis. Brain. 2009;132(pt 12):3380-3391.

5. Feinstein A. An examination of suicidal intent in patients with multiple sclerosis. Neurology. 2002;59(5):674-678.

Pages

Recommended Reading

Lapses in DMT Increases Risk of Relapse in MS Patients
ICYMI Multiple Sclerosis
Cannabis Misuse in MS Linked to Anxiety, Depression
ICYMI Multiple Sclerosis
Patient registry sheds light on the economic impact of MS
ICYMI Multiple Sclerosis
Pediatric MS May Go Untreated in Year After Diagnosis
ICYMI Multiple Sclerosis
Eculizumab Cuts Relapse Risk in NMO Spectrum Disorder
ICYMI Multiple Sclerosis
Ibudilast’s Efficacy Differs in Primary and Secondary Progressive MS
ICYMI Multiple Sclerosis
Age does not influence cladribine’s efficacy in MS
ICYMI Multiple Sclerosis
Neutrophils may decline in patients on fingolimod
ICYMI Multiple Sclerosis
Functional GI disorders are common in MS
ICYMI Multiple Sclerosis
Black holes are associated with impaired cognition in MS
ICYMI Multiple Sclerosis